DK510384D0 - Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf - Google Patents

Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf

Info

Publication number
DK510384D0
DK510384D0 DK510384A DK510384A DK510384D0 DK 510384 D0 DK510384 D0 DK 510384D0 DK 510384 A DK510384 A DK 510384A DK 510384 A DK510384 A DK 510384A DK 510384 D0 DK510384 D0 DK 510384D0
Authority
DK
Denmark
Prior art keywords
intravenoes
preparing
injection
procedure
pharmaceutical preparation
Prior art date
Application number
DK510384A
Other languages
English (en)
Other versions
DK510384A (da
Inventor
Peter Serno
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK510384D0 publication Critical patent/DK510384D0/da
Publication of DK510384A publication Critical patent/DK510384A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
DK510384A 1983-10-28 1984-10-25 Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf DK510384A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833339236 DE3339236A1 (de) 1983-10-28 1983-10-28 Arzneimittelzubereitung

Publications (2)

Publication Number Publication Date
DK510384D0 true DK510384D0 (da) 1984-10-25
DK510384A DK510384A (da) 1985-04-29

Family

ID=6213011

Family Applications (1)

Application Number Title Priority Date Filing Date
DK510384A DK510384A (da) 1983-10-28 1984-10-25 Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf

Country Status (14)

Country Link
US (1) US4711902A (da)
EP (1) EP0143305A1 (da)
JP (1) JPS60115517A (da)
KR (1) KR850002953A (da)
AU (1) AU3358784A (da)
DE (1) DE3339236A1 (da)
DK (1) DK510384A (da)
ES (1) ES8604419A1 (da)
FI (1) FI844199L (da)
GR (1) GR80788B (da)
HU (1) HU193908B (da)
IL (1) IL73318A (da)
NO (1) NO844144L (da)
ZA (1) ZA848375B (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE3624624A1 (de) * 1986-07-18 1988-01-28 Asche Ag Xylometazolinhaltige pharmazeutische praeparate
DE3626908A1 (de) * 1986-08-08 1988-02-11 Bayer Ag Parenterale loesung
JPS6348214A (ja) * 1986-08-18 1988-02-29 Morishita Seiyaku Kk １−〔２−（２，４−ジクロロフエニル）−３−メチル−１−ペンテニル〕−１ｈ−イミダゾ−ルを含有する水中油型脂肪乳剤
DE3682208D1 (de) * 1986-12-18 1991-11-28 Kurt Heinz Bauer Gegenueber lichteinfluss stabilisiertes nifedipin-konzentrat und verfahren zu seiner herstellung.
FR2609714A1 (fr) * 1987-01-15 1988-07-22 Sanofi Sa Compositions liquides stables a base de derives antifongiques imidazoles
US4895876A (en) * 1987-03-20 1990-01-23 Air Products And Chemicals, Inc. Concentrated stable fluorochemical aqueous emulsions containing triglycerides
ES2033086T3 (es) * 1988-01-29 1993-03-01 Sankyo Company Limited Un procedimiento para la preparacion de una composicion farmaceutica.
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
JPH02184633A (ja) * 1988-11-23 1990-07-19 Abbott Lab エイズ治療剤
BE1003647A5 (fr) * 1989-02-28 1992-05-12 Syntex Inc Composition pharmaceutique de nicardipine pour administration parenterale.
JP2732918B2 (ja) * 1989-10-31 1998-03-30 ライオン株式会社 口腔清浄剤組成物
JP3074731B2 (ja) * 1989-12-01 2000-08-07 日本新薬株式会社 脂肪乳剤
WO1991007964A1 (en) * 1989-12-01 1991-06-13 Nippon Shinyaku Co., Ltd. Fat emulsion
TW211015B (da) * 1990-01-11 1993-08-11 Nippon Shinyaku Co Ltd
WO1992007571A1 (fr) * 1990-11-06 1992-05-14 Nippon Shinyaku Co., Ltd. Procede de production d'une emulsion grasse
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
AU668509B2 (en) * 1991-04-19 1996-05-09 Affinity Biotech, Inc. Convertible microemulsion formulations
SE9303744D0 (sv) * 1993-11-12 1993-11-12 Astra Ab Pharmaceutical emulsion
EP0682943B1 (de) * 1994-05-20 2003-08-20 GESELLSCHAFT FÜR MEDIZINISCHE FORSCHUNG UND WEITERBILDUNG e.V. GMF Lormetazepamhaltige Öl-in-Wasser-Emulsion
US7205279B2 (en) * 1995-10-25 2007-04-17 Novartis Ag Pharmaceutical compositions
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
CA2338703C (en) 1998-08-19 2009-03-24 Rtp Pharma Inc. Injectable aqueous dispersions of propofol
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US20020025953A1 (en) * 2000-08-17 2002-02-28 Gordon Katherine D. Novel formulations for administering therapeutic lipophilic molecules
JP2005507754A (ja) * 2001-11-08 2005-03-24 アトリウム メディカル コーポレイション 治療薬を含有するコーティングを有する管腔内装置
KR100848755B1 (ko) * 2002-01-02 2008-07-25 주식회사 두산 포스파티딜세린 함유 액상 조성물 및 그 제조방법
DK1509492T3 (da) * 2002-01-25 2011-11-28 Theravance Inc Sedative hypnotiske midler med kort virkningsvarighed til anæstesi og sedation
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
WO2005009420A2 (en) * 2003-07-23 2005-02-03 Theravance, Inc. Pharmaceutical compositions of short-acting sedative hypnotic agent
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2006036984A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Stand-alone film and methods for making the same
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
BRPI0500520A (pt) * 2005-02-16 2006-09-26 Henry Jun Suzuki uso de agentes flavorizantes aromáticos de alto ponto de fusão como agentes solubilizantes ou inibidores de cristalização em composições farmacêuticas
BRPI0501120A (pt) * 2005-02-18 2006-10-03 Henry Jun Suzuki composições farmacêuticas orais e parenterais contendo altas concentrações de agentes solubilizantes aromáticos
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
NZ572226A (en) * 2006-04-18 2011-05-27 Ekr Therapeutics Inc Pre-mixed, ready-to-use IV bolus compositions comprising nicardipine and methods of use
US9416065B2 (en) * 2007-02-12 2016-08-16 Archer Daniels Midland Company Adjuvants and methods of using them
DE102007058785B3 (de) * 2007-12-06 2009-08-20 Hewitech Gmbh & Co. Kg Zusammensteckbare Entwässerungs- und/oder Drainagevorrichtung
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
KR20130062282A (ko) * 2010-05-13 2013-06-12 아스트라제네카 아베 진정 수면제의 주사가능한 에멀젼
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
WO2013093823A2 (en) 2011-12-20 2013-06-27 Vyome Biosciences Pvt Ltd Topical oil composition for the treatment of fungal infections
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
EP2983714A2 (en) * 2013-04-12 2016-02-17 Vyome Biosciences Pvt. Ltd. Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
CN104622806B (zh) * 2015-02-04 2018-03-16 北京蓝丹医药科技有限公司 一种丙泮尼地药物组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE592881C (de) * 1932-03-27 1934-02-16 Carl Weill Dr Verfahren zur Herstellung haltbarer, fuer Injektionszwecke geeigneter Emulsionen vonin Wasser unloeslichen oder schwer loeslichen Arzneimitteln
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
DE1792410B2 (de) * 1967-09-01 1980-03-13 Apoteksvarucentralen Vitrum Apotekareaktiebolaget, Stockholm Arzneimittelzubereitung zur intravenösen Injektion
DE1963188A1 (de) * 1969-12-17 1971-06-24 Bayer Ag Neue Cyanphenyl-1,4-dihydropyridinderivate
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2837477A1 (de) * 1978-08-28 1980-03-13 Bayer Ag Sila-substituierte 1,4-dihydropyridin- derivate
DE2935573A1 (de) * 1979-09-03 1981-03-19 Lepharm- Pharmazeutische Entwicklungs- und Vertriebsgesellschaft GmbH, 5000 Köln Infusionsloesungen mit mono- und diglyceriden von fettsaeuren
JPS5665820A (en) * 1979-11-02 1981-06-03 Eisai Co Ltd Hard capsule with high content of tocopherol nicotinate
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
AU3358784A (en) 1985-05-02
ES8604419A1 (es) 1986-02-01
DK510384A (da) 1985-04-29
FI844199A0 (fi) 1984-10-25
KR850002953A (ko) 1985-05-28
US4711902A (en) 1987-12-08
GR80788B (en) 1985-02-20
JPS60115517A (ja) 1985-06-22
EP0143305A1 (de) 1985-06-05
IL73318A0 (en) 1985-01-31
ES537022A0 (es) 1986-02-01
HU193908B (en) 1987-12-28
HUT36703A (en) 1985-10-28
NO844144L (no) 1985-04-29
DE3339236A1 (de) 1985-05-09
IL73318A (en) 1988-06-30
FI844199L (fi) 1985-04-29
ZA848375B (en) 1985-06-26

Similar Documents

Publication Publication Date Title
DK510384A (da) Laegemiddeltilberedning til intravenoes injektion samt fremgangsmaadetil fremstilling heraf
DK52189A (da) Farmaceutisk praeparat indeholdende igf i samt fremgangsmaade til fremstilling deraf
DK147488A (da) Benzoxazolderivat samt fremgangsmaade til fremstilling deraf
DK328083D0 (da) Opvaskemiddel samt fremgangsmade til fremstilling deraf
DK307883A (da) Carbostyrilderivater samt fremgangsmaade til fremstilling deraf
DK165361C (da) Praeparater med indkapslede partikler samt fremgangsmaade til fremstilling deraf
DK28985D0 (da) Stabilt humant gamma-interferonpraeparat samt fremgangsmaade til fremstilling deraf
DK64183D0 (da) Farmaceutisk praeparat samt fremgangsmade til fremstilling deraf
DK116380A (da) Bradykninhaemmende tripeptidforbindelser fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK642588D0 (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK114584A (da) Fast farmaceutisk praeparat samt fremgangsmaade til fremstilling deraf
DK469189A (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK160283C (da) Farmaceutisk iodoforpraeparat samt fremgangsmaade til fremstilling deraf
DK115685D0 (da) Prespap samt fremgangsmaade til fremstilling deraf
DK364483D0 (da) 14-aminosteroid-derivater samt fremgangsmade til fremstilling deraf
DK614589A (da) Imidazolholdige peptider samt fremgangsmaade til fremstilling deraf
DK191684D0 (da) Hydroxylerede diphenylazomethinderivater samt fremgangsmaade til fremstilling deraf
DK404587D0 (da) 5-deoxy-5-flourkanamycin b-derivater samt fremgangsmaader til fremstilling deraf
DK191584D0 (da) Substituerede diphenylazomethinderivater samt fremgangsmaade til fremstilling deraf
DK401786A (da) Substituerede cyclohexanalkansyrer samt fremgangsmaade til fremstilling deraf
DK166387C (da) Penemestere, en fremgangsmaade til fremstilling heraf samt et farmaceutisk praeparat indeholdende disse
DK160827C (da) Pteridinderivater, fremgangsmaade til fremstilling heraf samt farmaceutisk praeparat
DK354789D0 (da) Alkenyltetrazolderivater samt fremgangsmaade til fremstilling deraf
DK458082A (da) 2-isopropylamino-pyrimidin-n-oxid samt fremgangsmaade til fremstilling deraf
DK74581A (da) N-substituerede imido-dicarboxylsyrediarylestere samt fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
ATS Application withdrawn